Drug Chatter -- Tracking biopharma stock chatter

Profile for Gilead Sciences, Inc. (GILD)

« Back to company index

GILD Chatter Timeline

Stock Ticker for GILD

Most Active Tweeters for GILD

UserTweets
@pharm_specialty 19
@dakotafinancial 11
@TaxHavens 11
@SleekMoneycom 11
@TickerReport 10

Recent Tweets for GILD

Lin_ling_88 @Lin_ling_88
Some analysts calls Gilead's earnings "the biggest of beats" but unconvinced the company has turned corner. $GILD https://t.co/jyJs24PC9I
12:07am
TurboResearch @TurboResearch
$GILD My prediction for M&A...Gilead takes it up a notch, buys CRISPR tech. I would, if I ran $GILD.
July 27th 2017, 11:07pm
paynej247 @paynej247
RT @NassarInvesting: I really like $GILD for a possible short opportunity. $IBB is starting to turn downwards and GILD hasn't gotten the m…
July 27th 2017, 11:07pm
NassarInvesting @NassarInvesting
I really like $GILD for a possible short opportunity. $IBB is starting to turn downwards and GILD hasn't gotten the memo yet.
July 27th 2017, 11:07pm
RonaldLiu3 @RonaldLiu3
$GILD Monthly chart showing a change in trend. https://t.co/zlGm6iFaEj
July 27th 2017, 11:07pm
CancerWallonia @CancerWallonia
RT @1stOncology: #GileadSciences World-Wide Sales for #ZYDELIG was 35m USD in Q2 2017 (Down 15%) $GILD https://t.co/EqqWEZh23I
July 27th 2017, 11:07pm
Brandenmart @Brandenmart
RT @RatingsNetwork: Gilead Sciences's hold rating reiterated at Jefferies Group LLC. $83.00 PT. https://t.co/8J77casnZV $GILD #GILD
July 27th 2017, 10:07pm
Brandenmart @Brandenmart
RT @RatingsNetwork: Gilead Sciences's outperform rating reiterated at BMO Capital Markets. $82.00 PT. https://t.co/ppxCsrU2cy $GILD #GILD
July 27th 2017, 10:07pm
Brandenmart @Brandenmart
RT @RatingsNetwork: Gilead Sciences's buy rating reiterated at Deutsche Bank AG. $81.00 PT. https://t.co/Vuv2QCzDew $GILD #GILD
July 27th 2017, 10:07pm
RatingsNetwork @RatingsNetwork
Gilead Sciences's buy rating reiterated at Deutsche Bank AG. $81.00 PT. https://t.co/Vuv2QCzDew $GILD #GILD
July 27th 2017, 10:07pm
pratap1297 @pratap1297
RT @JBoorman: $GILD held up well. Looks good on weekly. https://t.co/AYoF3xn8Lf
July 27th 2017, 10:07pm
TaxHavens @TaxHavens
Commented on Gilead: The Doubters Were Wrong https://t.co/BeNUdMz7aX $GILD
July 27th 2017, 9:07pm
RatingsNetwork @RatingsNetwork
Gilead Sciences's outperform rating reiterated at BMO Capital Markets. $82.00 PT. https://t.co/ppxCsrU2cy $GILD #GILD
July 27th 2017, 9:07pm
jrombs @jrombs
RT @_B_I_O_T_E_C_H_: Barclays $GILD Initial Guidance Proves Overly Conservative, Results in a Beat; #UPGRADE to Market Weight (from Un…
July 27th 2017, 9:07pm
BioPharmaDive @BioPharmaDive
Despite sales drops, some analysts think $GILD's hep C declines could be flattening out https://t.co/FsoNdTe0iL
July 27th 2017, 6:07pm
AlpacaAlerts @AlpacaAlerts
$GILD is in Doji Gap Up winning 60.66% in the past. https://t.co/IuRhjNiVhh
July 27th 2017, 6:07pm
RatingsNetwork @RatingsNetwork
Gilead Sciences's hold rating reiterated at Jefferies Group LLC. $83.00 PT. https://t.co/8J77casnZV $GILD #GILD
July 27th 2017, 5:07pm
JBoorman @JBoorman
$GILD held up well. Looks good on weekly. https://t.co/AYoF3xn8Lf
July 27th 2017, 5:07pm
ARatings @ARatings
Jefferies Sticks to Their Hold Rating for Gilead Sciences $GILD https://t.co/V3F5NBztqu
July 27th 2017, 4:07pm
srqstockpicker @srqstockpicker
RT @CaesarBiotech: Q2'17 $GILD #HBV update 1. GS-9620 TLR7 agonist erased from HBV pipeline 2. Gilead established a second collaboration wi…
July 27th 2017, 4:07pm
1stOncology @1stOncology
#GileadSciences World-Wide Sales for #ZYDELIG was 35m USD in Q2 2017 (Down 15%) $GILD https://t.co/EqqWEZh23I
July 27th 2017, 4:07pm
TaxHavens @TaxHavens
$GILD What? someone painted the tape with 2 shares bought at $74.26 AH? Maybe just playin' wit ya!
July 27th 2017, 4:07pm
TaxHavens @TaxHavens
$GILD UP YTD 4.75% - and going higher.
July 27th 2017, 4:07pm
TaxHavens @TaxHavens
$GILD 13M shares held "Short"/short interest 1%. Vol today 14M shares Up .83 on a day NASDAQ got slammed. Tomorrow gonna be another winner.
July 27th 2017, 4:07pm
mench90 @mench90
RT @SeekingAlpha: Glaxo Runs Into Double Trouble In HIV https://t.co/uIElctqNSj $GILD $GSK
July 27th 2017, 3:07pm
CNBCTradersFan @CNBCTradersFan
RT SeekingAlpha "Glaxo Runs Into Double Trouble In HIV https://t.co/ZFRMltEWaq $GILD $GSK"
July 27th 2017, 3:07pm
SeekingAlpha @SeekingAlpha
Glaxo Runs Into Double Trouble In HIV https://t.co/uIElctqNSj $GILD $GSK
July 27th 2017, 3:07pm
blacktietrader @blacktietrader
$GILD still long from 200dma https://t.co/MaI548nE5e
July 27th 2017, 3:07pm
SleekMoneycom @SleekMoneycom
Jolley Asset Management LLC Buys 2,213 Shares of Gilead Sciences, Inc. $GILD https://t.co/eEdy6FmNwZ
July 27th 2017, 3:07pm
BioWino @BioWino
@JohnsHopkins2 @abbynac They are waiting. Ah la $gild. They think they are smarter than the market. Meanwhile the o… https://t.co/xvx0YckyCk
July 27th 2017, 3:07pm
dailymailtimes @dailymailtimes
Gilead Sciences, Inc. $GILD Position Boosted by Nisa Investment Advisors LLC https://t.co/3inPqfVQ2M
July 27th 2017, 3:07pm
paynej247 @paynej247
RT @AnthonyMaceroni: $GILD vol not all that impressive. Was looking to establish a long stock pos but I'll just keep calls until I see more…
July 27th 2017, 3:07pm
pharm_specialty @pharm_specialty
#GileadSciences Gilead's educational campaign boosted HCV diagnosis rates for baby boomers. Read more: https://t.co/eiMpoeUrQL $GILD
July 27th 2017, 3:07pm
AnthonyMaceroni @AnthonyMaceroni
$GILD vol not all that impressive. Was looking to establish a long stock pos but I'll just keep calls until I see more institutional buying
July 27th 2017, 3:07pm
JorgeGeorges24 @JorgeGeorges24
Everything is red , except for $GILD ... Strange AF .
July 27th 2017, 2:07pm
SleekMoneycom @SleekMoneycom
Spirit of America Management Corp NY Continues to Hold Stake in Gilead Sciences, Inc. $GILD https://t.co/Lk50g7mXf0
July 27th 2017, 2:07pm
BioPharmaDive @BioPharmaDive
Could HCV market be nearing bottom for $GILD? https://t.co/C2YgtDJ3WL
July 27th 2017, 2:07pm
stockassassin74 @stockassassin74
$gild holding like a champ in this nasty manipulated dump
July 27th 2017, 2:07pm
AjTrader7 @AjTrader7
$GILD Item#8 SHORT/LONG This was quick trade, told everyone watch any pull at open to the $75 level or lower go LONG https://t.co/4w3DG4xWup
July 27th 2017, 2:07pm
sak386 @sak386
RT @bradloncar: $GILD Finally - the BD question. Answer: no change to our thinking. We're very active evaluating opportunities.
July 27th 2017, 12:07am
surveyist @surveyist
RT @AndyBiotech: $GILD #HCV franchise sales up ~10% QoQ, first sign of stabilizing? Slide mention inventory build in US and deferred reven…
July 26th 2017, 11:07pm
surveyist @surveyist
RT @bradloncar: $GILD hep C lifecycle after tonight's number. https://t.co/9q6Y0ZqPJr
July 26th 2017, 11:07pm
BennettHopkins @BennettHopkins
RT @adamfeuerstein: $GILD $36.6B in cash…
July 26th 2017, 11:07pm
Lin_ling_88 @Lin_ling_88
$GILD swinging again.?positive trend of moneyflow started in June and non-abating... Time for LEAP calls https://t.co/dyvObzDDum
July 26th 2017, 10:07pm
1MinuteStock @1MinuteStock
We calculated 21-day Expected Return of $GILD for you: 4.81% https://t.co/mTgAzTSiLD
July 26th 2017, 10:07pm
pharm_specialty @pharm_specialty
#GileadSciences Gilead Revises 2017 Guidance. Read more: https://t.co/z1JhpHMRfV $GILD
July 26th 2017, 10:07pm
pharm_specialty @pharm_specialty
#GileadSciences Gilead's Hepatitis C Franchise Topples Again, But Shares Up On Beat. Read more: https://t.co/fJ4S3anBKJ $GILD
July 26th 2017, 10:07pm
thomasKlegend @thomasKlegend
$GILD back on the watch list. We are seeing a meaningful reversal on the chart. Better than expected results. RSI > 70 magic formula pick.
July 26th 2017, 10:07pm
1MinuteStock @1MinuteStock
Explore #fundamental numbers and pros and cons for $GILD https://t.co/IFnkAQiwhE
July 26th 2017, 10:07pm
AU_Analyst13 @AU_Analyst13
RT @Datamonitor_KMS: $GILD HCV hanging in there, but will it hold them over until NASH and other pipeline start to pay off. 36.6bn in cash…
July 26th 2017, 10:07pm

Contact © thinkBiotech LLC 2004 - 2017. All rights reserved.